Home » Topics » Regulatory » Patents

Patents
RSS

Potent analgesic agents from HMR with additional pharmacological effects

Oct. 2, 1998

ADIR claims 2-aminoindanes for CNS disorders involving serotonergic system dysfunction

Oct. 2, 1998

Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika

Oct. 1, 1998

Agents for dementia a focus of R&D at Sanofi

Oct. 1, 1998

Peptides that bind to MHC class II proteins in development at Zeneca

Oct. 1, 1998

Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders

Oct. 1, 1998

Neurogen compounds interacting with CRF1 receptors for stress-related disorders

Oct. 1, 1998

BASF patents new series with endothelin-antagonist activity

Oct. 1, 1998

Novel erythromycins from HMR useful for Gram-positive and other infections

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...